Evaluation of the interaction between melatonin and rapamycin for head and neck cancer therapy
Year: 2018
Type: dissertation
Abstract: Melatonin (N-acetyl-5-methoxytryptamine) is a potent free radical scavenger\nwith anti-oxidant and anti-inflammatory properties, which has well-known functions\nin immune system regulation, modulation of mitochondrial activity, and regulation of\ncell death and autophagy. Moreover, melatonin has attracted attention as a natural\noncostatic agent that can suppress neoplastic growth in a variety of tumours. Possible\nmechanisms of melatonin oncostasis induce direct and indirect antioxidant effects,\nregulation of metabolism, anti-angiogenic and antimetastatic effects, the capacity to\ndecrease telomerase activity and the ability to regulate the immune system. Notably,\nmelatonin also induces downregulation of the phosphorylation of mTOR and Akt in\nvarious cancers. Melatonin shows synergistic anticancer activity and amelioration of\nthe side effects of several chemotherapies and thus is a potential adjuvant in\nchemotherapy, with the ability to protect normal cells from a variety of insults. In\nlight of these properties, melatonin seems potentially useful as a combined anti-cancer\nagent to enhance the therapeutic effect of rapamycin and to minimize the toxic side\neffects of this drug in HNSCC. mTOR inhibitor treatment is associated with a number\nof adverse events in cancer patients, being mucositis the most frequent adverse effect\nleading to dose reduction or interruption of therapy. We recently demonstrated that a\nmelatonin gel prevents mucosal disruption and ulcer formation associated with oral\nmucositis.\nIn the present study, we aimed to elucidate the effects of melatonin on\nrapamycin-induced HNSCC cell death, and to identify potential cross-talk pathways.\nWe analyzed the dose-dependent effects of melatonin in rapamycin-treated HNSCC cell lines (Cal-27 and SCC-9). These cells were treated with 0.1, 0.5, or 1 mM\nmelatonin combined with 20 nM rapamycin. We further examined the potential\nsynergistic effects of melatonin with rapamycin in Cal-27 xenograft mice.\nRelationships between inhibition of the mTOR pathway, reactive oxygen species\n(ROS), and apoptosis and mitophagy reportedly increased the cytotoxic effects of\nrapamycin in HNSCC.
Author: Yingqiang Shen
Institution: Universidad de Granada
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2788963205
